Clinical Accelerator Leadership The CRI Anna-Maria Kellen Clinical Accelerator is led by the field’s top scientific and clinical talent and a highly experienced senior management team. Clinical Accelerator Clinical and Scientific Advisory Committee Chair Jedd D. Wolchok, MD, PhD Weill Cornell Medicine Clinical Accelerator Clinical and Scientific Advisory Committee Nina Bhardwaj, MD, PhD Icahn School of Medicine at Mount Sinai Elizabeth M. Jaffee, MD Johns Hopkins University School of Medicine Kunle Odunsi, MD, PhD The University of Chicago Julie R. Brahmer, MD Johns Hopkins George Coukos, MD, PhD Ludwig Cancer Research and University Hospitals of Canton Vaud (CHUV) Lawrence Fong, MD University of California, San Francisco F. Stephen Hodi, MD Dana-Farber Cancer Institute Dirk Jaeger, MD National Center for Tumor Diseases Heidelberg Carl H. June, MD University of Pennsylvania School of Medicine Antoni Ribas, MD, PhD University of California, Los Angeles Comprehensive Cancer Center Michel Sadelain, MD, PhD Memorial Sloan Kettering Cancer Center Neil H. Segal, MD, PhD Memorial Sloan Kettering Cancer Center Padmanee Sharma, MD, PhD The University of Texas MD Anderson Cancer Center Craig L. Slingluff Jr., MD University of Virginia Health System Pramod K. Srivastava, MD, PhD University of Connecticut School of Medicine Marcel van den Brink, MD, PhD Memorial Sloan Kettering Cancer Center Robert H. Vonderheide, MD, DPhil University of Pennsylvania E. John Wherry, PhD University of Pennsylvania School of Medicine Cassian Yee, MD The University of Texas MD Anderson Cancer Center CRI Clinical Accelerator and Venture Fund Management Team Jay Campbell Managing Director, CRI Clinical Accelerator and Venture Fund Ana Rosa Sáez Ibáñez, PhD Research Analyst, Clinical Accelerator and Venture Fund Jill O’Donnell-Tormey, PhD Chief Executive Officer and Director of Scientific Affairs Samik Upadhaya, PhD Assistant Director, Scientific Affairs
